Andrographis Recalls: Concerns Over Allergy Risk

Reason
Consumers are advised that the medicines listed below containing Andrographis paniculata (Andrographis) are being recalled due to the risk of severe allergic reactions.
Classification
Class I
Category
drug recall
Country
Australia
Agency
Therapeutic Goods Administration
Recall date
2026-10-01
Status
Ongoing
Distribution
Australia-wide

Official recall notice from Therapeutic Goods Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/96fd5d6b-dc61-4a32-8429-96771b476e51